MarketCap
Facebook
X
TelegramQuarterly report 2022-Q1
added 12-16-2023
R1 RCM Income Statement 2011-2026 | RCM
Annual Income Statement R1 RCM
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
7.24 B | 3.2 B | 1.37 B | 1.07 B | 670 M | 240 M | 254 M | 560 M | - | - | - |
Shares |
266 M | 116 M | 112 M | 108 M | 102 M | 100 M | 96.8 M | 95.8 M | - | - | - |
Historical Prices |
27.2 | 27.6 | 12.3 | 9.89 | 6.56 | - | - | - | - | - | - |
Net Income |
97.2 M | 117 M | 12 M | -45.3 M | -58.8 M | 177 M | -84.3 M | -79.6 M | 130 M | -120 M | 29.2 M |
Revenue |
1.47 B | 1.27 B | 1.19 B | 868 M | 450 M | 593 M | 117 M | 210 M | 505 M | 72.3 M | 826 M |
Cost of Revenue |
1.16 B | 1.02 B | 988 M | 771 M | 416 M | 200 M | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | 393 M | -51.7 M | 28 M | 318 M | -116 M | 196 M |
Operating Income |
146 M | 80 M | 57.7 M | -30.4 M | -27.5 M | 298 M | -136 M | -129 M | 204 M | -188 M | -120 M |
EBITDA |
223 M | 149 M | 113 M | 8.4 M | -11.2 M | 329 M | -118 M | -35.8 M | 245 M | -178 M | 56.4 M |
Operating Expenses |
- | 102 M | 114 M | 102 M | 56.3 M | 74.1 M | 75 M | 69.9 M | 80 M | 67.8 M | 148 M |
General and Administrative Expenses |
120 M | 102 M | 104 M | 97.9 M | 56.3 M | 74.1 M | 75 M | 69.9 M | 80 M | - | 148 M |
All numbers in USD currency
Quarterly Income Statement R1 RCM
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
- | - | - | 279 M | 278 M | 279 M | 268 M | 239 M | 121 M | 116 M | 115 M | 114 M | 114 M | 112 M | 111 M | 110 M | 111 M | 109 M | 108 M | 106 M | 104 M | 102 M | 102 M | 101 M | 107 M | 101 M | 99.4 M | 98.3 M | 108 M | 97.2 M | 95.9 M | 95.9 M | 98.1 M | 95.8 M | 95.8 M | 95.7 M | 96 M | 95.7 M | 95.7 M | 95.7 M | 95.7 M | 99.4 M | 99.4 M | 98.9 M | 98.7 M | 97.8 M | 96.6 M | 95.2 M |
Net Income |
- | - | - | 29.4 M | - | 17 M | 18.4 M | 25.8 M | - | 5.2 M | 15.1 M | 18.2 M | 7.8 M | 9.2 M | -5.2 M | 200 K | -5.7 M | -13.4 M | -2.9 M | -23.3 M | -40.2 M | -3.6 M | -6.7 M | -8.3 M | 13.1 M | 37.3 M | -40.8 M | 167 M | 5.45 M | -33 M | -26.3 M | -30.4 M | -17.7 M | 9.55 M | -16.8 M | -54.7 M | 6.39 M | -37.6 M | 188 M | -26.5 M | -28.9 M | -31.4 M | -31.4 M | -28.1 M | -608 K | -22.2 M | -24 M | -25 M |
Revenue |
- | - | - | 386 M | - | 380 M | 353 M | 343 M | - | 307 M | 315 M | 320 M | 314 M | 301 M | 295 M | 276 M | 263 M | 250 M | 208 M | 147 M | 140 M | 123 M | 99.4 M | 86.9 M | - | 22.7 M | - | 343 M | - | - | - | - | - | - | - | - | - | - | - | - | - | 223 M | 237 M | 254 M | 260 M | 219 M | 184 M | 164 M |
Cost of Revenue |
- | - | - | 296 M | - | 304 M | 287 M | 267 M | - | 255 M | 248 M | 254 M | - | 242 M | 246 M | 237 M | - | 219 M | 190 M | 139 M | - | 112 M | 96.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 46.2 M | 45.3 M | 44.7 M | 65.6 M | 49 M | 47.1 M | 34.2 M |
Operating Income |
- | - | - | 43.2 M | - | 31.1 M | 27.6 M | 36.8 M | - | 10.6 M | 25.1 M | 32.4 M | 14.3 M | 23.6 M | 12.4 M | 7.4 M | 3.9 M | -5.8 M | -17.7 M | -10.8 M | -3.7 M | -5.1 M | -10.2 M | -8.5 M | 27.5 M | 61.4 M | -69.8 M | 279 M | 10.9 M | -54.8 M | -42.3 M | -49.9 M | -31.6 M | 14.7 M | -27.2 M | -84.6 M | 9.96 M | -60.9 M | 298 M | -42.5 M | -46.9 M | -47.9 M | -49.1 M | -44 M | 66 K | -37.4 M | -40.7 M | -42 M |
EBITDA |
- | - | - | 62.1 M | - | 38.2 M | 31.9 M | 54.7 M | - | 61.5 M | 58.7 M | 48.1 M | 14.3 M | 63.5 M | 38.2 M | 20.3 M | 3.9 M | 21.8 M | -4.3 M | -5.9 M | -3.7 M | -600 K | -6.4 M | -5.3 M | 27.5 M | 64.1 M | -67.5 M | 281 M | 10.9 M | -52.1 M | -40.2 M | -48.1 M | -31.6 M | 16.1 M | -25.7 M | -83.2 M | 9.96 M | -55.7 M | 301 M | -40.7 M | -46.9 M | -47.9 M | -49.1 M | -41.5 M | 66 K | -31.1 M | -36.6 M | -40 M |
Operating Expenses |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 39.8 M | 46.6 M | 42.4 M | - | 36.8 M | 33.8 M | 33.8 M |
General and Administrative Expenses |
- | - | - | 28.9 M | - | 33.2 M | 29 M | 25.6 M | - | 25.7 M | 23.3 M | 25.5 M | - | 28.3 M | 25.8 M | 22.5 M | - | 29.6 M | 22.5 M | 17 M | - | 15.1 M | 12.2 M | 14.3 M | - | 16.2 M | 24.6 M | 17.6 M | - | 21.4 M | 21 M | 17.4 M | - | 16.8 M | 19.5 M | 17.4 M | - | 22.6 M | 18.7 M | 22.1 M | - | 17.7 M | 15.4 M | 17.8 M | - | 14.9 M | 12.7 M | 14.3 M |
All numbers in USD currency
The income statement is one of the three key financial reports of a company R1 RCM (alongside the balance sheet and the cash flow statement). It shows how the company makes money and what its expenses are:
- How much revenue the company earned
- How much it spent on production, personnel, marketing, taxes, etc.
- What profit remained in the end
Analyzing the income statement helps an investor understand whether the business generates stable and growing profits, how effectively the company controls its expenses, and whether it is capable of generating income in the future. Additionally, this analysis shows how the company copes with crises and economic cycles, and allows assessing the potential for stock price growth and dividend payments.
Features- The income statement may include both recurring and one-time items (for example, profit from the sale of assets). It is necessary to separate core metrics from one-off events for accurate analysis.
- Companies often publish interim reports (e.g., quarterly), which allows for more timely tracking of trends.
- A combined analysis of the income statement with the balance sheet and cash flow statement provides a comprehensive view of the company’s financial health.
Reports on the profits and losses of other stocks in the Health information services industry
| Issuer | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|
 |
American Well Corporation
AMWL
|
$ 5.52 | 1.1 % | $ 88.6 M |  USA |
 |
Accolade
ACCD
|
- | 0.29 % | $ 206 M | USA |
 |
Cerner Corporation
CERN
|
- | - | $ 27.9 B | USA |
 |
Covetrus
CVET
|
- | - | $ 2.94 B | USA |
 |
Computer Programs and Systems
CPSI
|
- | 4.4 % | $ 133 M | USA |
 |
Castlight Health, Inc.
CSLT
|
- | -7.28 % | $ 227 M | USA |
 |
HMS Holdings Corp.
HMSY
|
- | - | $ 3.29 B | USA |
 |
Inovalon Holdings, Inc.
INOV
|
- | - | $ 6.37 B | USA |
 |
iCAD
ICAD
|
- | - | $ 102 M | USA |
 |
HealthStream
HSTM
|
$ 21.86 | -0.86 % | $ 664 M | USA |
 |
Akerna Corp.
KERN
|
- | - | $ 161 M | USA |
 |
Evolent Health
EVH
|
$ 3.35 | -5.77 % | $ 314 M | USA |
 |
HealthEquity
HQY
|
$ 80.0 | -1.42 % | $ 6.85 B | USA |
 |
Allscripts Healthcare Solutions
MDRX
|
- | -10.39 % | $ 886 M | USA |
 |
Change Healthcare
CHNG
|
- | - | $ 9.03 B | USA |
 |
So-Young International
SY
|
$ 2.91 | 1.04 % | $ 231 M |  China |
 |
MTBC
MTBC
|
- | -0.58 % | $ 51.7 M | USA |
 |
Omnicell
OMCL
|
$ 41.91 | 0.92 % | $ 1.93 B | USA |
 |
1Life Healthcare
ONEM
|
- | - | $ 3.37 B | USA |
 |
GoodRx Holdings
GDRX
|
$ 2.28 | 4.59 % | $ 879 M | USA |
 |
Health Catalyst
HCAT
|
$ 1.92 | -1.79 % | $ 116 M | USA |
 |
Progyny
PGNY
|
$ 17.61 | -1.01 % | $ 1.51 B | USA |
 |
Premier
PINC
|
- | - | $ 2.33 B | USA |
 |
NantHealth
NH
|
- | -46.64 % | $ 10.4 M | USA |
 |
OptimizeRx Corporation
OPRX
|
$ 7.66 | -2.67 % | $ 131 M | USA |
 |
NextGen Healthcare
NXGN
|
- | - | $ 1.6 B | USA |
 |
Phreesia
PHR
|
$ 12.11 | -4.12 % | $ 661 M | USA |
 |
Schrödinger
SDGR
|
$ 12.96 | -1.26 % | $ 952 M | USA |
 |
Teladoc Health
TDOC
|
$ 5.11 | -0.49 % | $ 900 M | USA |
 |
Zhongchao
ZCMD
|
$ 1.71 | 2.4 % | $ 8.9 M | China |
 |
Signify Health
SGFY
|
- | -0.02 % | $ 7.21 B | USA |
 |
Streamline Health Solutions
STRM
|
- | - | $ 21.4 M | USA |
 |
10x Genomics
TXG
|
$ 21.85 | -2.32 % | $ 2.56 B | USA |
 |
Tabula Rasa HealthCare
TRHC
|
- | - | $ 255 M | USA |
 |
Veeva Systems
VEEV
|
$ 195.36 | 3.65 % | $ 31.4 B | USA |
 |
SCWorx Corp.
WORX
|
$ 0.13 | -4.02 % | $ 190 K | USA |